Inspection Record

Kohl & Frisch Limited — Health Canada Inspection Findings

Health CanadaInspected 2022-12-19 5 findingsStability and storageOther quality systemEquipment and facility

View the regulator's official source The source document is always the basis for judgement.

Findings

1Stability and storage

The evidence used to demonstrate the transportation and/or storage conditions of each lot or batch of the drug was inadequate. The temperature and/or humidity control was inadequate.

2Other quality system

The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.

3Equipment and facility

The premises were not designed, constructed, and/or maintained to prevent the entry of pests and/or foreign material into the building.

4Equipment and facility

The maintenance of personnel records was inadequate.

5Other quality system

The implementation of a self-inspection program was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-12-19. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Kohl & Frisch Limited company profile — full history Health Canada documents, 2022 Go to Findings search